5-HT1A Partial Agonists. What is Their Future?

Overview

Journal Drugs

Specialty Pharmacology

Date 1991 Jan 1

PMID 1706983

Citations 3

Authors

D A Glitz

R Pohl

Affiliations

Soon will be listed here.

Citing Articles

Anticonflict and discriminative stimulus effects in the pigeon of a new methoxy-chroman 5-HT1A agonist, (+)S 20244 and its enantiomers (+)S 20499 and (-)S 20500.

Barrett J, Gamble E, Zhang L, Guardiola-Lemaitre B Psychopharmacology (Berl). 1994; 116(1):73-8.

PMID: 7862933 DOI: 10.1007/BF02244873.

Anxiety in elderly patients. A comparison of azapirones and benzodiazepines.

Steinberg J Drugs Aging. 1994; 5(5):335-45.

PMID: 7833587 DOI: 10.2165/00002512-199405050-00003.

(-)Tertatolol is a potent antagonist at pre- and postsynaptic serotonin 5-HT1A receptors in the rat brain.

Jolas T, Lanfumey L, Fattaccini C, Kidd E, Adrien J, Gozlan H Naunyn Schmiedebergs Arch Pharmacol. 1993; 347(5):453-63.

PMID: 7686633 DOI: 10.1007/BF00166735.

References

Feighner J, COHN J . Analysis of individual symptoms in generalized anxiety--a pooled, multistudy, double-blind evaluation of buspirone. Neuropsychobiology. 1989; 21(3):124-30. DOI: 10.1159/000118565. View

Pecknold J, Matas M, Howarth B, Ross C, Swinson R, Vezeau C . Evaluation of buspirone as an antianxiety agent: buspirone and diazepam versus placebo. Can J Psychiatry. 1989; 34(8):766-71. DOI: 10.1177/070674378903400804. View

Kahn R, Westenberg H . L-5-hydroxytryptophan in the treatment of anxiety disorders. J Affect Disord. 1985; 8(2):197-200. DOI: 10.1016/0165-0327(85)90046-1. View

Insel T, Murphy D, Cohen R, Alterman I, Kilts C, Linnoila M . Obsessive-compulsive disorder. A double-blind trial of clomipramine and clorgyline. Arch Gen Psychiatry. 1983; 40(6):605-12. DOI: 10.1001/archpsyc.1983.04390010015002. View

Rickels K . Recent advances in anxiolytic therapy. J Clin Psychiatry. 1981; 42(11 Pt 2):40-4. View

Cott J, Kurtz N, Robinson D, LANCASTER S, Copp J . A 5-HT1A ligand with both antidepressant and anxiolytic properties. Psychopharmacol Bull. 1988; 24(1):164-7. View

Engel J, Hjorth S, Svensson K, Carlsson A, Liljequist S . Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). Eur J Pharmacol. 1984; 105(3-4):365-8. DOI: 10.1016/0014-2999(84)90634-4. View

Harto N, Branconnier R, Spera K, Dessain E . Clinical profile of gepirone, a nonbenzodiazepine anxiolytic. Psychopharmacol Bull. 1988; 24(1):154-60. View

MENDELS J, Frazer A . Brain biogenic amine depletion and mood. Arch Gen Psychiatry. 1974; 30(4):447-51. DOI: 10.1001/archpsyc.1974.01760100019004. View

10.

Thoren P, Asberg M, CRONHOLM B, Jornestedt L, Traskman L . Clomipramine treatment of obsessive-compulsive disorder. I. A controlled clinical trial. Arch Gen Psychiatry. 1980; 37(11):1281-5. DOI: 10.1001/archpsyc.1980.01780240079009. View

11.

McMILLEN B, Scott S, Williams H, Sanghera M . Effects of gepirone, an aryl-piperazine anxiolytic drug, on aggressive behavior and brain monoaminergic neurotransmission. Naunyn Schmiedebergs Arch Pharmacol. 1987; 335(4):454-64. DOI: 10.1007/BF00165563. View

12.

Rickels K, Weisman K, Norstad N, Singer M, Stoltz D, Brown A . Buspirone and diazepam in anxiety: a controlled study. J Clin Psychiatry. 1982; 43(12 Pt 2):81-6. View

13.

Bruno F . Buspirone in the treatment of alcoholic patients. Psychopathology. 1989; 22 Suppl 1:49-59. DOI: 10.1159/000284626. View

14.

McDaniel J, Ninan P, Magnuson J . Possible induction of mania by buspirone. Am J Psychiatry. 1990; 147(1):125-6. DOI: 10.1176/ajp.147.1.125. View

15.

Peroutka S, Sleight A, McCarthy B, Pierce P, Schmidt A, Hekmatpanah C . The clinical utility of pharmacological agents that act at serotonin receptors. J Neuropsychiatry Clin Neurosci. 1989; 1(3):253-62. DOI: 10.1176/jnp.1.3.253. View

16.

Giral P, MARTIN P, Soubrie P, Simon P . Reversal of helpless behavior in rats by putative 5-HT1A agonists. Biol Psychiatry. 1988; 23(3):237-42. DOI: 10.1016/0006-3223(88)90034-0. View

17.

Asberg M, Nordstrom P, Traskman-Bendz L . Cerebrospinal fluid studies in suicide. An overview. Ann N Y Acad Sci. 1986; 487:243-55. DOI: 10.1111/j.1749-6632.1986.tb27903.x. View

18.

Lidberg L, Tuck J, Asberg M, Bertilsson L . Homicide, suicide and CSF 5-HIAA. Acta Psychiatr Scand. 1985; 71(3):230-6. DOI: 10.1111/j.1600-0447.1985.tb01279.x. View

19.

Young S, Teff K . Tryptophan availability, 5HT synthesis and 5HT function. Prog Neuropsychopharmacol Biol Psychiatry. 1989; 13(3-4):373-9. DOI: 10.1016/0278-5846(89)90126-7. View

20.

Ratey J, Sovner R, Mikkelsen E, Chmielinski H . Buspirone therapy for maladaptive behavior and anxiety in developmentally disabled persons. J Clin Psychiatry. 1989; 50(10):382-4. View